1T-AL-LAD

1T-AL-LAD
Identifiers
IUPAC name
  • (6aR,9R)-4-(thiophen-2-ylcarbonyl)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
Chemical and physical data
FormulaC27H29N3O2S
Molar mass459.61 g·mol−1
3D model (JSmol)
SMILES
  • O=C(n1cc2C[C@H]3N(C[C@@H](C=C3c3cccc1c32)C(=O)N(CC)CC)CC=C)c1sccc1
InChI
  • InChI=InChI=1S/C27H29N3O2S/c1-4-12-29-16-19(26(31)28(5-2)6-3)14-21-20-9-7-10-22-25(20)18(15-23(21)29)17-30(22)27(32)24-11-8-13-33-24/h4,7-11,13-14,17,19,23H,1,5-6,12,15-16H2,2-3H3/t19-,23-/m1/s1
  • Key:BMJBFHKDQQECIJ-AUSIDOKSSA-N

1T-AL-LAD is a psychedelic lysergamide derivative which has been sold as a designer drug, first reported in April 2024. It is believed to act as a prodrug for AL-LAD in a similar manner to how 1P-LSD acts as a prodrug for LSD.[1]

See also

References

  1. ↑ Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Kanamori T, et al. (June 2024). "Synthesis and analytical characterization of 1-(2-thienoyl)-6-allyl-nor-d-lysergic acid diethylamide (1T-AL-LAD)". Drug Testing and Analysis. doi:10.1002/dta.3747. PMID 38922764.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.